HRT Financial’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

HRT Financial’s Portfolio VCNX Stock Details VCNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-79	Closed	-$21K	–	3904
2022 Q1	$21K	Buy	+79	New	+$21.8K	﹤0.01%	2831

Other funds holding VCNX

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

HRT Financial's VCNX Position: Q2 2022 in Review

HRT Financial sold out of Vaccinex, Inc. Common Stock (VCNX) in Q2 2022, closing a stake of 79 shares — an estimated $21K sold.

HRT Financial first reported a position in VCNX in Q1 2022 and held it in 1 quarter. The position peaked at $21K in Q1 2022. 27 funds tracked by Wall St. Rank hold VCNX as of Q2 2022.

HRT Financial reported no remaining Vaccinex, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
HRT Financial sold 79 Vaccinex, Inc. Common Stock shares in Q2 2022, an estimated $21K.
HRT Financial first reported a position in Vaccinex, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
HRT Financial's Vaccinex, Inc. Common Stock position peaked at $21K in Q1 2022.
27 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q2 2022.

Based on HRT Financial's 13F filing for Q2 2022, filed 12 Aug 2022.